Lymphoma & Multiple Myeloma Pharmacist @NorthwesternMed | PGY1 & PGY2 Onc @MayoClinic | 🩸🧬🦠💊
Chicago, IL
Joined June 2010
- Tweets54
- Following251
- Followers157
- Likes189
Divya Khandekar, PharmD, MS, BCOP retweeted
We've got your weekend listening sorted - check out the latest episode of #HOPANow🎙️with guests @pharmdiv @LeAnnBNorrisand @lakenned93 breaking down their unusual hobbies, and how they strike the perfect work-life balance. Listen Now: apple.co/3R77xA9
Divya Khandekar, PharmD, MS, BCOP retweeted
The next #HOPANow🎙️ episode is almost here - make sure to catch up on our discussion with @pharmdiv @LeAnnBNorris and @lakenned93 breaking down their unusual hobbies and how they strike the perfect work-life balance. Listen Now: apple.co/3R77xA9
Divya Khandekar, PharmD, MS, BCOP retweeted
In this Q&A, Stefan Barta, MD, of @PennMedicine, discusses how a deeper understanding of peripheral T-cell #lymphoma biology is shaping treatment selection and emerging therapeutic strategies.
📰 Read here: buff.ly/jCrt36y
Divya Khandekar, PharmD, MS, BCOP retweeted
It’s always the generic drops that melt people’s eyeballs. Generics are great for things like ibuprofen and acetaminophen. For your eyes, stick to name brands: Refresh, Systane, Blink, Thera Tears
FDA warns 26 eye drop products, including from store brands such as CVS, Target and Rite Aid, could lead to serious infections or vision loss. trib.al/QpBubS2
Divya Khandekar, PharmD, MS, BCOP retweeted
I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives.
1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.
Divya Khandekar, PharmD, MS, BCOP retweeted
I’m really proud of this study. After 20 years since inception, we got the final completion from CIRB today.
The trial changed myeloma treatment— a lot of lives saved simply by reducing steroid dose. @eaonc @Rfonsi1 @mtmdphd @NorthTxMSG @TheLancetOncol thelancet.com/journals/lanon…
Divya Khandekar, PharmD, MS, BCOP retweeted
#TwitteRx folks attending #ASHP22 in Vegas 📢: Remember to verify your COVID-19 vaccination status before arriving! You can’t get a meeting badge without doing so! @ASHPOfficial #PharmICU
Divya Khandekar, PharmD, MS, BCOP retweeted
Divya A. Khandekar, PharmD, MS @pharmdiv - "Pharmacologic Management of Radiation Therapy (RT) Toxicities"
Pharmacology CE available for pharmacists, physicians, physician assistants, and nurse practitioners.
#TwitteRx @MayoMedEd
apple.co/3hecxkR
Divya Khandekar, PharmD, MS, BCOP retweeted
Taylor Swift’s Anti-Hero music video as it pertains to infectious diseases:
#IDTwitter
#TwitteRx – at Virginia, USA
Divya Khandekar, PharmD, MS, BCOP retweeted
Mayo Clinic & Mayo Clinic Health System sites are hosting a virtual information session on 11/07 from 5-6 PM central! 11 different PGY2 programs from Rochester (MN), Mankato (MN), and Eau Claire (WI) will be present. Register now!
Divya Khandekar, PharmD, MS, BCOP retweeted
To #oncopharm learners, over the next several months I will try to share tips on appraising drug literature in oncology🩸🧬. From fundamentals to more advanced tips to help you become more analytical 🧐 #TwitteRx
Divya Khandekar, PharmD, MS, BCOP retweeted
In today's Pharmacy Grand Rounds, @MayoClinic PGY2 oncology resident @pharmdiv discusses pharmacologic management of radiation therapy (RT) toxicities. #TwitteRx #OncoPharm @MayoRadOnc
Want a copy of slides or pharmacy CE? Subscribe to our PGR Podcast!
Divya Khandekar, PharmD, MS, BCOP retweeted
Congratulations to @garrett_schramm and Ben Anderson on achieving FASHP in @ASHPOfficial. @MayoPharmRes is lucky to have you both!
Divya Khandekar, PharmD, MS, BCOP retweeted
UPenn study shows that vanc-piptazo ⬆️ *creatinine* but actually causes a trend towards ⬇️Cystatin C. this dissociation between Cr vs. renal biomarker implies that piptazo is a pseudonephrotoxin that ⬇️ Cr secretion, w/o hurting the kidney (1/2) @Miano81
vimeo.com/523925430
Divya Khandekar, PharmD, MS, BCOP retweeted
Now OF: In a single-arm, multicentre, ph 2 study of venetoclax plus 3+7 daunorubicin and cytarabine in adults with AML, the composite complete remission rate after one cycle was 91% (95% CI 76–98; 30 of 33 patients) #leusm
thelancet.com/journals/lanha…
Divya Khandekar, PharmD, MS, BCOP retweeted
Week ✌️of Orientation down! Looking forward to a great year ahead with these awesome Co-Residents! @ABeaudrieRx @NikithaYagnala @pharmdiv @JoAnnLeal6 @MayoPharmRes Only 1 more co-resi we need to persuade to join #TwitteRx #ScottsTots 👀
Divya Khandekar, PharmD, MS, BCOP retweeted
The true tragedy of #India - the land of #KishoriAmonkar today worships the cult of Honey Singh. We delight in strangling our civilisation.